About

Elevating human life through scientific innovation.

Science

Developing gene therapies to reduce patient suffering.

Pipeline

Explore our gene therapy pipeline.

Investors & Newsroom

Stay updated on our latest research and company news.

Community

Community

Community

Publication

Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration

(Shim, Juwon, et al. "Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration." Molecular Therapy Methods & Clinical Development 32.4 (2024).)

View publication